Advances in infertility care in India

Infertility is growing at an alarming pace, especially in metros with frequently carried negative psychosocial implications. Of the 60 - 80 million couples suffering from infertility globally every year, between 15 - 20 million are in India alone. With advances in technology, the success rate of assisted reproduction has steadily increased in the past few years. Today the success rate of such procedures is around 35 to 40 percent.

Webinar symposium

Dr Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on the Diagnosis & Management of Normal & Assisted Reproductive Technologies on Sunday, 22nd June 2014 between 4PM and 6PM. You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com A Q & A session will follow the Doctors presentation.
About the Speakers:
1.    Dr. Nimmi Kansal, MBBS, MD, HOD, Biochemistry & Immunoassay, Dr Lal PathLabs.
2.    Dr. Indrani Ganguli, MBBS, MD, FICOG, FIMSA, FICMCH, All India Vice President FOGSI.

Novel opportunities in non invasive antenatal diagnosis and fetal therapeutics

Fetal laboratory medicine offers a pioneer opportunity for diagnostic testing, forging the frontier of maternal–fetal medicine. Clinical trends in antenatal technologies today give us the future directions in noninvasive prenatal diagnostics for fetal health assessment.  A webinar is being conducted to showcase new advances in this field that will discuss the current scope and contributions of fetal laboratory testing.

Webinar symposium

Dr Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on the Diagnosis & Management of Normal & Assisted Reproductive Technologies on Sunday, 22nd June 2014 between 4PM and 6PM. You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com A Q & A session will follow the Doctors presentation.
About the Speakers:
1.    Dr. Nimmi Kansal, MBBS, MD, HOD, Biochemistry & Immunoassay, Dr Lal PathLabs.
2.    Dr. Indrani Ganguli, MBBS, MD, FICOG, FIMSA, FICMCH, All India Vice President FOGSI.

Redefining infertility and its prevalence: a contemporary approach

Recent advances in assisted reproductive technology, particularly at a genetic level, have helped us to better understand the causes of infertility, and also to offer techniques that maximize the safety and efficiency of treatment and therefore the chance of a successful outcome. Fertility assistance, whether minimal or high level, aims to optimize the chances of having a singleton pregnancy and the birth of a healthy baby.

Webinar symposium

Dr Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on the Diagnosis & Management of Normal & Assisted Reproductive Technologies on Sunday, 22nd June 2014 between 4PM and 6PM. You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com A Q & A session will follow the Doctors presentation.
About the Speakers:
1.    Dr. Nimmi Kansal, MBBS, MD, HOD, Biochemistry & Immunoassay, Dr Lal PathLabs.
2.    Dr. Indrani Ganguli, MBBS, MD, FICOG, FIMSA, FICMCH, All India Vice President FOGSI.

Latest advances in diagnostic tools and techniques for treating infertility

Infertility is a common medical condition which can have devastating, painful, and life-long effects extending to personal relationships and wider family. This condition affects 20% of young couples and is increasing over the past decade.  Advancement in various reproductive technologies now offers the most effective treatments in a timely manner to people experiencing problems in conceiving.

Webinar symposium

Dr Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on the Diagnosis & Management of Normal & Assisted Reproductive Technologies on Sunday, 22nd June 2014 between 4PM and 6PM. You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com A Q & A session will follow the Doctors presentation.
About the Speakers:
1.    Dr. Nimmi Kansal, MBBS, MD, HOD, Biochemistry & Immunoassay, Dr Lal PathLabs.
2.    Dr. Indrani Ganguli, MBBS, MD, FICOG, FIMSA, FICMCH, All India Vice President FOGSI.

Webinar symposium On the Frontier of Maternal–Fetal Medicine

Emerging antenatal interventions and care delivery to the fetus require diagnostic support, including laboratory technologies, appropriate methodologies, establishment of special algorithms, and interpretative guidelines for clinical decision-making. To hear more on these topics you are cordially invited to participate in the free webinar by registering online.
 
Webinar symposium

Dr Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on the Diagnosis & Management of Normal & Assisted Reproductive Technologies on Sunday, 22nd June 2014 between 4PM and 6PM. You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com A Q & A session will follow the Doctors presentation.
About the Speakers:

1. Dr. Nimmi Kansal, MBBS, MD, HOD, Biochemistry & Immunoassay, Dr Lal PathLabs.

2. Dr. Indrani Ganguli, MBBS, MD, FICOG, FIMSA, FICMCH, All India Vice President FOGSI.

Problem with TB drugs and vaccine

Emergence of drug resistance TB in the recent years has posed a great problem with handling the disease. Irregular and misuse of TB drug isoniazid has been one of the major causes for it. Co-infection of TB with HIV makes handling the disease even more complex for administration of anti tuberculosis drugs.  Also, the major vaccine against the disease, Baccillus Calmette-Guerin (BCG) has its own side effects and in some cases has been inefficient in preventing the disease.

Webinar symposium

Need of the hour surely is to find a better way to handle it by reducing the flaws in diagnosis, treatment and better prevention of TB. 24th March is observed as the World TB day, and Dr. Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on Breakthrough in Diagnosis and Effective Treatment of TB. The webinar will be webcast on Sunday, 30th of March 2014 between 11 AM to 1 PM from Hotel Claridges, New Delhi. You are cordially invited to participate in the free webinar by registering online. A Q & A session will follow the Doctors presentation.

You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com

About the Speakers:

1.      Dr. Shalabh Malik, Head of the Microbiology Department, Dr. LalPath labs

2.      Dr. Animesh Arya, MBBS, DTCD, MD. Senior chest consultant and sleep specialist at Action Balaji medical institute and Max healthcare, Medical director at centre for chest diseases, allergy and sleep disorders.

Dr. Lal PathLabs introduces a breakthrough webinar on diagnosis and effective treatment of TB, click to know more -  http://www.drlalpathlabswebinar.com "

Why is TB still a major problem in India?

WHO recommended a strategy to control TB in the world called directly observed treatment, short course (DOTS) which includes; political commitment, case detection, standardization of treatment, adequate drug supply, monitoring and evaluation of its impact. In India however this strategy has been failing due to several reasons: Lack of commitment from the government, inefficiency of handling a large population with TB,   lack of information for poor people regarding the disease and its control, lack of patient follow up are few of the several problems associated with it.

Webinar symposium

Dr. Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on Breakthrough in Diagnosis and Effective Treatment of TB on the occasion of the World TB day on 24th March. The webinar will be webcast on Sunday, 30th of March 2014 between 11 AM to 1 PM from Hotel Claridges, New Delhi. You are cordially invited to participate in the free webinar by registering online. A Q & A session will follow the Doctors presentation.

You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com

About the Speakers:

1.      Dr. Shalabh Malik, Head of the Microbiology Department, Dr. LalPath labs

2.      Dr. Animesh Arya, MBBS, DTCD, MD. Senior chest consultant and sleep specialist at Action Balaji medical institute and Max healthcare, Medical director at centre for chest diseases, allergy and sleep disorders.

Dr. Lal PathLabs introduces a breakthrough webinar on diagnosis and effective treatment of TB, click to know more -  http://www.drlalpathlabswebinar.com "

Latent TB infection in India

India has a very high number of latent TB infection cases (LTBI) around the world. The diagnosis and treatment of LTBI are equally important as it later develops into active form. Tb when not diagnosed and treated at its first stage develops into more complex forms called drug resistive TB and extensively drug resistive TB.

Webinar symposium

24^th March is observed as the World TB day, and Dr. Lal PathLabs, the leading and the most reputed diagnostic chain, presents a webinar symposium on Breakthrough in Diagnosis and Effective Treatment of TB. The webinar will be webcast on Sunday, 30th of March 2014 between 11 AM to 1 PM from Hotel Claridges, New Delhi. You are cordially invited to participate in the free webinar by registering online. A Q & A session will follow the Doctors presentation.

You can register free for the webinar on the following URL: www.drlalpathlabswebinar.com

About the Speakers:

1.      Dr. Shalabh Malik, Head of the Microbiology Department, Dr. LalPath labs

2.      Dr. Animesh Arya, MBBS, DTCD, MD. Senior chest consultant and sleep specialist at Action Balaji medical institute and Max healthcare, Medical director at centre for chest diseases, allergy and sleep disorders.

Dr. Lal PathLabs introduces a breakthrough webinar on diagnosis and effective treatment of TB, click to know more -  http://www.drlalpathlabswebinar.com "

Status of TB in India

Congratulations! India for now officially being a polio free country, however, the same cannot be said on the status of TB in India. Even after decades of introduction of numerous TB control programs, India is host to maximum number of TB patients around the world. Several diagnostic advancements have been made in the fields like smear microscopy, rapid culture, Mycobacterium tuberculosis and non-tuberculous mycobacteria differentiation, in-house PCR assays, serological tests etc. Effective disease management in India can be achieved by simply validating and applying these methods in a lab or a public health setting.

Webinar symposium

To provide a better understanding of the new, improved TB diagnostic methods and treatment options available in India, Dr. Lal Path Labs, the leading and the most reputed diagnostic chain, presents a webinar symposium on the topic “Breakthrough in Diagnosis and Effective Treatment of TB.” The webinar will be webcast on Sunday, 30th of March 2014 between 11 AM to 1 PM from Hotel Claridges, New Delhi. You are cordially invited to participate in the free webinar by registering online. A Q & A session will follow the Doctors presentation.

Register free for the webinar on the following URL: www.drlalpathlabswebinar.com NOW!!

About the Speakers:

1.      Dr. Shalabh Malik, Head of the Microbiology Department, Dr. Lal PathLabs

2.      Dr. Animesh Arya, MBBS, DTCD, MD. Senior chest consultant and sleep specialist at Action Balaji medical institute and Max healthcare, Medical director at centre for chest diseases, allergy and sleep disorders.

" Dr. Lal PathLabs introduces a breakthrough webinar on diagnosis and effective treatment of TB, click to know more -  http://www.drlalpathlabswebinar.com "

TB IN INDIA- THE GRAVE SITUATION

World Health Organisation’s 2011 statistics state that with an estimated figure of 2.2 million cases of TB, India remains the highest TB burden country of the world. The recently discovered phenomenon of TDR-TB has worsened the scene. The drug-resistance rate in India is higher than the global average by 2 to 3%. The efforts of Tuberculosis Association of India and Revised National TB Control Programme have improved the scenario tremendously, but TB still kills around 3,00,000 people in our country, every year. Researches have proved that isoniazid and rifampicin, the two most powerful first line treatment anti-TB drugs fail when it comes to MDR-TB, which can only be diagnosed in specialized labs. Despite great advances in medicine, the situation remains grim.

Webinar symposium

Considering this precarious condition, Dr. Lal PathLabs, one of the most reputed diagnostic chains of India have taken a brilliant initiative of organizing a Webinar Symposium on the topic “Breakthrough in Diagnosis and Effective Treatment of TB.” The webinar will be webcast on Sunday, 30^th March 2014, from 11 AM to 1 PM from Hotel Claridges, New Delhi. An informative Q & A session will follow the insightful presentations. You are cordially invited to participate in this free webinar by registering online.

You can register free for the webinar here: www.drlalpathlabswebinar.com

About the Speakers:

1. Dr. Shalabh Malik, Head of the Microbiology Department, Dr. LalPath labs

2. Dr. Animesh Arya, MBBS, DTCD, MD. Senior chest consultant and sleep specialist at Action Balaji medical institute and Max healthcare, Medical director at centre for chest diseases, allergy and sleep disorders. 

" Dr. Lal PathLabs introduces a breakthrough webinar on diagnosis and effective treatment of TB, click to know more -  http://www.drlalpathlabswebinar.com "